StoneCrest Wealth Management’s Viridian Therapeutics VRDN Stock Holding History

StoneCrest Wealth Management’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$350K	Sell
2025 Q1	$347K	Sell
2024 Q4	$496K	Sell
2024 Q3	$628K	Buy
2024 Q2	$358K	Sell
2024 Q1	$485K	Sell
2023 Q4	$605K	Buy